The notion that impairment can be assumed or not based solely on specific concentrations of THC or its metabolites in a driver’s blood or urine is plainly wrong.
The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.
There are several options provided by the US federal government that hemp and CBD businesses can take advantage of during these turbulent times.
If cannabis stores close, the state of Oregon would be depriving many patients who rely on retail cannabis stores access to their medicine. If retail cannabis stores remain open, does it make sense to limit access to medicinal patents?
Trademark registration is not simply a matter of racing to the USPTO to register a word or phrase that you wish to have exclusive rights to, even if you were the first to use the word or phrase.
I have observed that many people fail to “think properly” about how to handle financial downturns and find themselves thrashing in the dark, despite the fact that there are a number of simple and effective methods for managing cash flow that produce results.
As a service to our current clients and readers during these difficult times, we are offering a free 20-minute phone call to address your pressing issues – no strings attached.
In this article, I will provide a summary of THCA, delta-9 THC, delta-8 THC, THCP, THCV and then conclude with a discussion of the various laws that impact them.
For my talk, I compared and contrasted the hemp and CBD regulatory regimes in Europe and US. Although they parallel each other in some respects, particularly policy, they are fundamentally different in their approaches.
The FDA has yet to create a regulatory pathway for CBD. Does its most recent report to Congress herald a change?